ONCOSIL MEDICAL LTD - Announcements

0.47%

$1.08

Market Cap $20.23M

Healthcare Biotechnology

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

OSL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	451.24KB	Share
OSL	Appointment and Resignation of Company Secretary		23/07/25	143.6KB	Share
OSL	Completion of Recruitment in TRIPP-FFX Clinical Trial	PRICE SENSITIVE	23/07/25	109.43KB	Share
OSL	Change in substantial holding from SOL		15/07/25	440.13KB	Share
OSL	Change in substantial holding from PCG		15/07/25	369.17KB	Share
OSL	Change in substantial shareholding from AEF		15/07/25	202.84KB	Share
OSL	Application for quotation of securities - OSL		15/07/25	17.77KB	Share
OSL	Final Director's Interest Notice		11/07/25	121.59KB	Share
OSL	Initial Director's Interest Notice		11/07/25	115.3KB	Share
OSL	OSLOD Options Range of Units and Top 20 Holders		11/07/25	229.43KB	Share
OSL	Application for quotation of securities - OSL		11/07/25	30.34KB	Share
OSL	Application for quotation of securities - OSL		11/07/25	21.52KB	Share
OSL	OncoSil announces appointment of Non-Executive Director		11/07/25	102.33KB	Share
OSL	Proposed issue of securities - OSL		09/07/25	19.15KB	Share
OSL	Update - Proposed issue of securities - OSL		09/07/25	23.56KB	Share
OSL	Update - Proposed issue of securities - OSL		09/07/25	23.98KB	Share
OSL	Results of Meeting		08/07/25	170.27KB	Share
OSL	OSL completes $2 million Share Purchase Plan		07/07/25	79.19KB	Share
OSL	Completion of Recruitment in PANCOSIL Study	PRICE SENSITIVE	04/07/25	109.89KB	Share
OSL	Becoming a substantial shareholder from AEF		26/06/25	204.88KB	Share
OSL	Change of Directors Interest Notice Lel Smits		25/06/25	255.21KB	Share
OSL	Notification of cessation of securities - OSL		19/06/25	12.88KB	Share
OSL	Notification regarding unquoted securities - OSL		19/06/25	18.71KB	Share
OSL	Change in substantial holding from SOL		18/06/25	684.37KB	Share
OSL	Change in substantial holding from PCG		17/06/25	208.5KB	Share
OSL	Notice of Extraordinary General Meeting/Proxy Form		06/06/25	529.06KB	Share
OSL	Update - Consolidation/Split - OSL		06/06/25	19.94KB	Share
OSL	Capital Consolidation Complete		06/06/25	91.26KB	Share
OSL	Security Purchase Plan (SPP) Now Open		04/06/25	75.95KB	Share
OSL	Notice under section 708A		03/06/25	70.69KB	Share
OSL	Application for quotation of securities - OSL		03/06/25	15.73KB	Share
OSL	Update - Consolidation/Split - OSL		29/05/25	19.93KB	Share
OSL	Results of Meeting		29/05/25	138.59KB	Share
OSL	Proposed issue of securities - OSL		26/05/25	23.57KB	Share
OSL	Proposed issue of securities - OSL		26/05/25	22.85KB	Share
OSL	Proposed issue of securities - OSL		26/05/25	15.69KB	Share
OSL	Investor Presentation		26/05/25	1.29MB	Share
OSL	Prospectus	PRICE SENSITIVE	26/05/25	729.88KB	Share
OSL	OSL announces $8.7m capital raise to drive commercialisation	PRICE SENSITIVE	26/05/25	154.17KB	Share
OSL	Trading Halt	PRICE SENSITIVE	22/05/25	164.67KB	Share
OSL	OncoSil Outperforms SBRT in Pancreatic Cancer Outcomes		07/05/25	91.55KB	Share
OSL	Application for quotation of securities - OSL		05/05/25	15.53KB	Share
OSL	Quarterly Activities/Appendix 4C Cash Flow Report Addendum		02/05/25	756.09KB	Share
OSL	Update - Consolidation/Split - OSL		01/05/25	19.85KB	Share
OSL	Consolidation/Split - OSL	PRICE SENSITIVE	01/05/25	19.3KB	Share
OSL	Tender Process for CRO to Undertake G-BA Study Commences		30/04/25	87.08KB	Share
OSL	Notice of Extraordinary General Meeting/Proxy Form		30/04/25	677.83KB	Share
OSL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	751.12KB	Share
OSL	Appointment of Company Secretary		01/04/25	119.27KB	Share
OSL	OncoSil appoints Ms Shelley Steyn as Chief Financial Officer		18/03/25	114.7KB	Share
OSL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	25/02/25	952.98KB	Share
OSL	Investor Webinar Presentation		11/02/25	584.07KB	Share
OSL	Investor Webinar 11 February 2025		07/02/25	149.18KB	Share
OSL	120 German Hospitals entitled to negotiate fee for OncoSil	PRICE SENSITIVE	04/02/25	154.18KB	Share
OSL	Response to Appendix 3X Query		31/01/25	731.14KB	Share
OSL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	569.62KB	Share
OSL	Initial Director's Interest Notice LS		29/01/25	202.38KB	Share
OSL	OncoSil Medical Receives MDR Approval	PRICE SENSITIVE	28/01/25	206.34KB	Share
OSL	Lel Smits to be appointed Non-Executive Director		15/01/25	209.58KB	Share
OSL	OncoSil receives $1.05m R&D tax incentive	PRICE SENSITIVE	08/01/25	119.23KB	Share
OSL	First Patient in Australia Randomised in TRIPP-FFX Trial		31/12/24	149.15KB	Share
OSL	Change of Director's Interest Notice DC		20/12/24	150.93KB	Share
OSL	Notification regarding unquoted securities - OSL		13/12/24	16.12KB	Share
OSL	OSLOC Options Range of Units and Top 20 Holders		13/12/24	173.47KB	Share
OSL	Application for quotation of securities - OSL		13/12/24	15.88KB	Share
OSL	Application for quotation of securities - OSL		13/12/24	15.81KB	Share
OSL	Application for quotation of securities - OSL		13/12/24	15.66KB	Share
OSL	Oncosil completes $1 million Share Purchase Plan (SPP)	PRICE SENSITIVE	13/12/24	122.9KB	Share
OSL	Results of Meeting		11/12/24	150.16KB	Share
OSL	Constitution		29/11/24	354.66KB	Share
OSL	Notice under section 708A		28/11/24	131.79KB	Share
OSL	Application for quotation of securities - OSL		28/11/24	15.67KB	Share
OSL	Proposed issue of securities - OSL		27/11/24	14.81KB	Share
OSL	Results of Meeting		20/11/24	149.84KB	Share
OSL	AGM Chairman's Address and CEO & MD Presentation		20/11/24	2.63MB	Share
OSL	OncoSil Signs Distribution Agreements for Nordics and Egypt		18/11/24	149.75KB	Share
OSL	Investor Webinar Presentation		15/11/24	1.19MB	Share
OSL	Investor Webinar		13/11/24	127.6KB	Share
OSL	Notice of Extraordinary General Meeting December 2024		12/11/24	478.57KB	Share
OSL	First OncoSil Treatment at Instituto Nazionale dei Tumori		11/11/24	149.36KB	Share
OSL	Change in substantial holding from SOL		06/11/24	1.39MB	Share
OSL	Prospectus 2024 Share Purchase Plan (SPP) Offer	PRICE SENSITIVE	06/11/24	823.13KB	Share
OSL	Change in substantial holding from PCG		05/11/24	922.36KB	Share
OSL	Notice under section 708A		01/11/24	131.69KB	Share
OSL	Application for quotation of securities - OSL		01/11/24	15.65KB	Share
OSL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/24	415.74KB	Share
OSL	Amended Share Purchase Plan (SPP) Timetable		30/10/24	141.77KB	Share
OSL	Update - Proposed issue of securities - OSL		29/10/24	23.48KB	Share
OSL	OncoSil Appoints Rachel Duggan as EMEA Sales Director		29/10/24	136.98KB	Share
OSL	Proposed issue of securities - OSL		28/10/24	23.67KB	Share
OSL	Capital Raise Presentation		28/10/24	1.93MB	Share
OSL	Proposed issue of securities - OSL		28/10/24	19.21KB	Share
OSL	Proposed issue of securities - OSL		28/10/24	15.76KB	Share
OSL	OSL completes $7 M Placement and announces $1 M SPP	PRICE SENSITIVE	28/10/24	206.77KB	Share
OSL	G-BA Approval received for OncoSil Device	PRICE SENSITIVE	24/10/24	120.52KB	Share
OSL	Trading Halt	PRICE SENSITIVE	24/10/24	517.02KB	Share
OSL	Notice of Annual General Meeting		22/10/24	566.22KB	Share
OSL	OncoSil Medical Limited Receives UKCA Renewal Certificates		21/10/24	123.38KB	Share
OSL	OncoSil signs distribution agreement with Al Zahrawi Medical		07/10/24	154.98KB	Share
OSL	Application for quotation of securities - OSL		02/10/24	15.54KB	Share

OSL Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	451.24KB	Share
OSL Appointment and Resignation of Company Secretary
23/07/25		143.6KB	Share
OSL Completion of Recruitment in TRIPP-FFX Clinical Trial
23/07/25	PRICE SENSITIVE	109.43KB	Share
OSL Change in substantial holding from SOL
15/07/25		440.13KB	Share
OSL Change in substantial holding from PCG
15/07/25		369.17KB	Share
OSL Change in substantial shareholding from AEF
15/07/25		202.84KB	Share
OSL Application for quotation of securities - OSL
15/07/25		17.77KB	Share
OSL Final Director's Interest Notice
11/07/25		121.59KB	Share
OSL Initial Director's Interest Notice
11/07/25		115.3KB	Share
OSL OSLOD Options Range of Units and Top 20 Holders
11/07/25		229.43KB	Share
OSL Application for quotation of securities - OSL
11/07/25		30.34KB	Share
OSL Application for quotation of securities - OSL
11/07/25		21.52KB	Share
OSL OncoSil announces appointment of Non-Executive Director
11/07/25		102.33KB	Share
OSL Proposed issue of securities - OSL
09/07/25		19.15KB	Share
OSL Update - Proposed issue of securities - OSL
09/07/25		23.56KB	Share
OSL Update - Proposed issue of securities - OSL
09/07/25		23.98KB	Share
OSL Results of Meeting
08/07/25		170.27KB	Share
OSL OSL completes $2 million Share Purchase Plan
07/07/25		79.19KB	Share
OSL Completion of Recruitment in PANCOSIL Study
04/07/25	PRICE SENSITIVE	109.89KB	Share
OSL Becoming a substantial shareholder from AEF
26/06/25		204.88KB	Share
OSL Change of Directors Interest Notice Lel Smits
25/06/25		255.21KB	Share
OSL Notification of cessation of securities - OSL
19/06/25		12.88KB	Share
OSL Notification regarding unquoted securities - OSL
19/06/25		18.71KB	Share
OSL Change in substantial holding from SOL
18/06/25		684.37KB	Share
OSL Change in substantial holding from PCG
17/06/25		208.5KB	Share
OSL Notice of Extraordinary General Meeting/Proxy Form
06/06/25		529.06KB	Share
OSL Update - Consolidation/Split - OSL
06/06/25		19.94KB	Share
OSL Capital Consolidation Complete
06/06/25		91.26KB	Share
OSL Security Purchase Plan (SPP) Now Open
04/06/25		75.95KB	Share
OSL Notice under section 708A
03/06/25		70.69KB	Share
OSL Application for quotation of securities - OSL
03/06/25		15.73KB	Share
OSL Update - Consolidation/Split - OSL
29/05/25		19.93KB	Share
OSL Results of Meeting
29/05/25		138.59KB	Share
OSL Proposed issue of securities - OSL
26/05/25		23.57KB	Share
OSL Proposed issue of securities - OSL
26/05/25		22.85KB	Share
OSL Proposed issue of securities - OSL
26/05/25		15.69KB	Share
OSL Investor Presentation
26/05/25		1.29MB	Share
OSL Prospectus
26/05/25	PRICE SENSITIVE	729.88KB	Share
OSL OSL announces $8.7m capital raise to drive commercialisation
26/05/25	PRICE SENSITIVE	154.17KB	Share
OSL Trading Halt
22/05/25	PRICE SENSITIVE	164.67KB	Share
OSL OncoSil Outperforms SBRT in Pancreatic Cancer Outcomes
07/05/25		91.55KB	Share
OSL Application for quotation of securities - OSL
05/05/25		15.53KB	Share
OSL Quarterly Activities/Appendix 4C Cash Flow Report Addendum
02/05/25		756.09KB	Share
OSL Update - Consolidation/Split - OSL
01/05/25		19.85KB	Share
OSL Consolidation/Split - OSL
01/05/25	PRICE SENSITIVE	19.3KB	Share
OSL Tender Process for CRO to Undertake G-BA Study Commences
30/04/25		87.08KB	Share
OSL Notice of Extraordinary General Meeting/Proxy Form
30/04/25		677.83KB	Share
OSL Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	751.12KB	Share
OSL Appointment of Company Secretary
01/04/25		119.27KB	Share
OSL OncoSil appoints Ms Shelley Steyn as Chief Financial Officer
18/03/25		114.7KB	Share
OSL Appendix 4D and Half Year Accounts
25/02/25	PRICE SENSITIVE	952.98KB	Share
OSL Investor Webinar Presentation
11/02/25		584.07KB	Share
OSL Investor Webinar 11 February 2025
07/02/25		149.18KB	Share
OSL 120 German Hospitals entitled to negotiate fee for OncoSil
04/02/25	PRICE SENSITIVE	154.18KB	Share
OSL Response to Appendix 3X Query
31/01/25		731.14KB	Share
OSL Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	569.62KB	Share
OSL Initial Director's Interest Notice LS
29/01/25		202.38KB	Share
OSL OncoSil Medical Receives MDR Approval
28/01/25	PRICE SENSITIVE	206.34KB	Share
OSL Lel Smits to be appointed Non-Executive Director
15/01/25		209.58KB	Share
OSL OncoSil receives $1.05m R&D tax incentive
08/01/25	PRICE SENSITIVE	119.23KB	Share
OSL First Patient in Australia Randomised in TRIPP-FFX Trial
31/12/24		149.15KB	Share
OSL Change of Director's Interest Notice DC
20/12/24		150.93KB	Share
OSL Notification regarding unquoted securities - OSL
13/12/24		16.12KB	Share
OSL OSLOC Options Range of Units and Top 20 Holders
13/12/24		173.47KB	Share
OSL Application for quotation of securities - OSL
13/12/24		15.88KB	Share
OSL Application for quotation of securities - OSL
13/12/24		15.81KB	Share
OSL Application for quotation of securities - OSL
13/12/24		15.66KB	Share
OSL Oncosil completes $1 million Share Purchase Plan (SPP)
13/12/24	PRICE SENSITIVE	122.9KB	Share
OSL Results of Meeting
11/12/24		150.16KB	Share
OSL Constitution
29/11/24		354.66KB	Share
OSL Notice under section 708A
28/11/24		131.79KB	Share
OSL Application for quotation of securities - OSL
28/11/24		15.67KB	Share
OSL Proposed issue of securities - OSL
27/11/24		14.81KB	Share
OSL Results of Meeting
20/11/24		149.84KB	Share
OSL AGM Chairman's Address and CEO & MD Presentation
20/11/24		2.63MB	Share
OSL OncoSil Signs Distribution Agreements for Nordics and Egypt
18/11/24		149.75KB	Share
OSL Investor Webinar Presentation
15/11/24		1.19MB	Share
OSL Investor Webinar
13/11/24		127.6KB	Share
OSL Notice of Extraordinary General Meeting December 2024
12/11/24		478.57KB	Share
OSL First OncoSil Treatment at Instituto Nazionale dei Tumori
11/11/24		149.36KB	Share
OSL Change in substantial holding from SOL
06/11/24		1.39MB	Share
OSL Prospectus 2024 Share Purchase Plan (SPP) Offer
06/11/24	PRICE SENSITIVE	823.13KB	Share
OSL Change in substantial holding from PCG
05/11/24		922.36KB	Share
OSL Notice under section 708A
01/11/24		131.69KB	Share
OSL Application for quotation of securities - OSL
01/11/24		15.65KB	Share
OSL Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24	PRICE SENSITIVE	415.74KB	Share
OSL Amended Share Purchase Plan (SPP) Timetable
30/10/24		141.77KB	Share
OSL Update - Proposed issue of securities - OSL
29/10/24		23.48KB	Share
OSL OncoSil Appoints Rachel Duggan as EMEA Sales Director
29/10/24		136.98KB	Share
OSL Proposed issue of securities - OSL
28/10/24		23.67KB	Share
OSL Capital Raise Presentation
28/10/24		1.93MB	Share
OSL Proposed issue of securities - OSL
28/10/24		19.21KB	Share
OSL Proposed issue of securities - OSL
28/10/24		15.76KB	Share
OSL OSL completes $7 M Placement and announces $1 M SPP
28/10/24	PRICE SENSITIVE	206.77KB	Share
OSL G-BA Approval received for OncoSil Device
24/10/24	PRICE SENSITIVE	120.52KB	Share
OSL Trading Halt
24/10/24	PRICE SENSITIVE	517.02KB	Share
OSL Notice of Annual General Meeting
22/10/24		566.22KB	Share
OSL OncoSil Medical Limited Receives UKCA Renewal Certificates
21/10/24		123.38KB	Share
OSL OncoSil signs distribution agreement with Al Zahrawi Medical
07/10/24		154.98KB	Share
OSL Application for quotation of securities - OSL
02/10/24		15.54KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.08		Change 0.005(0.47%)		Mkt cap ! $20.23M

Open	High	Low	Value	Volume
$1.07	$1.08	$1.07	$498.0K	465.4K

Buyers (Bids)

No.	Vol.	Price($)
1	531	$1.07

Sellers (Offers)

Price($)	Vol.	No.
$1.08	8531	2

View Market Depth

No.	Vol.	Price($)
1	531	1.070
1	1975	1.065
2	5889	1.060
2	2654	1.050
2	2961	1.040

Price($)	Vol.	No.
1.075	8531	2
1.110	9892	1
1.120	6617	1
1.140	5000	1
1.145	5000	1

Last trade - 10.35am 01/08/2025 (20 minute delay)

OSL (ASX) Chart

ONCOSIL MEDICAL LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories